Number | Date | Country | Kind |
---|---|---|---|
937/95 | Apr 1995 | CHX | |
421/96 | Feb 1996 | CHX |
Filing Document | Filing Date | Country | Kind | 102e Date | 371c Date |
---|---|---|---|---|---|
PCT/EP96/01263 | 3/22/1996 | 10/3/1997 | 10/3/1997 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO96/31510 | 10/10/1996 |
Number | Name | Date | Kind |
---|---|---|---|
5686457 | Traxler et al. | Nov 1997 |
Number | Date | Country |
---|---|---|
566226 | Oct 1993 | EPX |
9220642 | Nov 1992 | WOX |
9519970 | Jul 1995 | WOX |
9519774 | Jul 1995 | WOX |
9640142 | Dec 1996 | WOX |
9814551 | Apr 1998 | WOX |
9814450 | Apr 1998 | WOX |
9814449 | Apr 1998 | WOX |
Entry |
---|
G. Dodin, et al., vol. 99, pp. 7257-7265, J. Am. Chem. Soc., 1977. |
K. Klem, vol. 114, No. 6, pp. 2001-2018, Chem. Ber., 1981. |
Traxler et al., "Use of Pharmacophore Model for the Design of EGF-R Tyrosine Kinase Inhibitors: 4-(Phenylamino) pyrazolo[3,4-d]pyrimidines," J. Med. Chem., vol. 40, No. 22, pp. 3601-3616, Oct. 24, 1997. |
Burke, "Protein-Tyrosine Kinases: Potential Targets for Anticancer Drug Development," Stem Cells, vol. 12, pp. 1-6, 1994. |